跳至主要内容
临床试验/NCT02082067
NCT02082067撤回4 期

Total Knee Arthroplasty & Outcome: A Prospective Randomized Comparison Between Adductor Canal Block and Femoral Nerve Block

ASST Gaetano Pini-CTO1 个研究点 分布在 1 个国家开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
发起方
试验地点
1
主要终点
Up and Go test

研究概览

简要总结

Aim of this study is to evaluate the effects of the adductor canal block on the early and medium term ( 1 month) rehabilitation compared to the continuous femoral block commonly used in the knee prosthesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing total knee arthroplasty

排除标准

  • neurological disorders
  • coagulation disorders
  • rheumatoid arthritis
  • chronic opioids therapy
  • allergy to local anesthetic

研究组 & 干预措施

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Ropivacaine 0,75% (Drug)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Adductor canal (Procedure)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Spinal Anesthesia (Procedure)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Local anesthetic infusion (Procedure)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Intravenous analgesia (Procedure)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Levobupivacaine 0,5% (Drug)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Levobupivacaine 0,125% (Drug)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Ketorolac 30mg (Drug)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: Morphine (Drug)

Adductor canal

Experimental

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

干预措施: stimulong sono, Pajunk, Germany (Device)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Femoral (Procedure)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Spinal Anesthesia (Procedure)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Local anesthetic infusion (Procedure)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Intravenous analgesia (Procedure)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Ropivacaine 0,75% (Drug)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Levobupivacaine 0,5% (Drug)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Levobupivacaine 0,125% (Drug)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Ketorolac 30mg (Drug)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: Morphine (Drug)

Femoral

Active Comparator

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

干预措施: stimulong sono, Pajunk, Germany (Device)

Controls

Placebo Comparator

No patients of this arm receive continuous nerve block. Intravenous opioids analgesia will be administered.

干预措施: Spinal Anesthesia (Procedure)

Controls

Placebo Comparator

No patients of this arm receive continuous nerve block. Intravenous opioids analgesia will be administered.

干预措施: Intravenous analgesia (Procedure)

Controls

Placebo Comparator

No patients of this arm receive continuous nerve block. Intravenous opioids analgesia will be administered.

干预措施: Levobupivacaine 0,5% (Drug)

Controls

Placebo Comparator

No patients of this arm receive continuous nerve block. Intravenous opioids analgesia will be administered.

干预措施: Ketorolac 30mg (Drug)

Controls

Placebo Comparator

No patients of this arm receive continuous nerve block. Intravenous opioids analgesia will be administered.

干预措施: Morphine (Drug)

结局指标

主要结局

Up and Go test

时间窗: 5th postoperative day

Knee functional evaluation at 5th postoperative day. "up and go" test: time need to get up from a chair, walk for 3 meters, and come back to seat down on the chair

次要结局

  • Falling risk(5th postoperative day)
  • VAS score(up to POD5)
  • Morphine request(up to POD5)
  • Range of motion(5th postoperative day)
  • Quadriceps strength(5th postoperative day)

研究者

发起方
ASST Gaetano Pini-CTO
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gianluca Cappelleri

Medical Doctor

ASST Gaetano Pini-CTO

研究点 (1)

Loading locations...

相似试验